RxDoctor Payments Data

Ricardo McCall, MD

Gastroenterology · Lake Charles, LANPI 1265413876

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.3% of the total across 568 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 27 manufacturers reported payments, led by AbbVie at 24.8% of the total. Reporting peaked in 2019 at $2,884 and has fallen 93.8% since, to $178 in 2024.

$11,049in general payments, 2019–2025

Across 568 payments — averaging $19.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$2K
  • Takeda Pharmaceuticals U.S.A., Inc.$899
  • Johnson & Johnson$875
  • Intercept Pharmaceuticals, Inc.$815
  • Gilead$599
  • plus $3K from 21 others
$462,993in research payments, 2019–2025

Across 269 payments — averaging $1721.16 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Bristol Myers Squibb$227K
  • AbbVie$156K
  • Shire North American Group Inc$42K
  • Takeda Pharmaceuticals U.S.A., Inc.$21K
  • Pfizer$6K
  • Eli Lilly$5K
  • plus $5K from 1 others

What the payments were for

  • Food & beverage$10,75097%
  • Education$2883%
  • Entertainment$100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,049 in reported general payments places this provider in the 80th percentile of 254 gastroenterology providers in Louisiana.

See all gastroenterology providers in Louisiana

Medicare billing

Part B allowed, 2024
$8,059
Medicare patients
46
Services billed
66

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Pantoprazole Sodium70$1,482

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Lake Charles

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →